A Variant PfCRT Isoform Can Contribute to <italic toggle="yes">Plasmodium falciparum</italic> Resistance to the First-Line Partner Drug Piperaquine

A Variant PfCRT Isoform Can Contribute to <italic toggle="yes">Plasmodium falciparum</italic> Resistance to the First-Line Partner Drug Piperaquine

ABSTRACT Current efforts to reduce the global burden of malaria are threatened by the rapid spread throughout Asia of Plasmodium falciparum resistance to artemisinin-based combination therapies, which includes increasing rates of clinical failure with dihydroartemisinin plus piperaquine (PPQ) in Cam...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Satish K. Dhingra, Devasha Redhi, Jill M. Combrinck, Tomas Yeo, John Okombo, Philipp P. Henrich, Annie N. Cowell, Purva Gupta, Matthew L. Stegman, Jonathan M. Hoke, Roland A. Cooper, Elizabeth Winzeler, Sachel Mok, Timothy J. Egan, David A. Fidock
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2017
Materias:
malaria
PfCRT
Plasmodium falciparum
artemisinin-based combination therapies
digestive vacuole
genome editing
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/9c6d366c3a2a445c9fb90b0de038bd88
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/9c6d366c3a2a445c9fb90b0de038bd88

Ejemplares similares